ZotepineA Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Schizophrenia

[1] Harada T(1986)Antimanic effect of zotepine Clin Ther 8 406-14

[2] Otsuki S(1994)Double-blind comparative study of zotepine and lithium carbonate on mania [abstract] Neuropsychopharmacology 10 40-93

[3] Fujiwara Y(1994)Pharmacotherapy of delusional depression: experience with combinations of anti-depressants with the neuroleptics zotepine and haloperidol Neuropsychobiology 29 189-60

[4] Harada T(1995)Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use Pharmacopsychiatry 28 56-59

[5] Otsuki S(1990)The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment Eur J Pharmacol 186 49-73

[6] Wolfersdorf M(1996)Risperidone compared with new and reference antipsychotic drugs: Psychopharmacology (Berl) 124 57-8

[7] König F(1996) and Psychopharmacol Bull 32 123-6

[8] Straub R(1996) receptor binding Eur Neuropsychopharmacol 6 105-12

[9] Wolfersdorf M(1990)Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile Clin Neuropharmacol 13 500-54

[10] Barg T(1982)Comparison of the pharmacological profiles of zotepine and norzotepine [abstract] Jpn J Pharmacol 32 405-4

[1] Harada T(1986)Antimanic effect of zotepine Clin Ther 8 406-14

[2] Otsuki S(1994)Double-blind comparative study of zotepine and lithium carbonate on mania [abstract] Neuropsychopharmacology 10 40-93

[3] Fujiwara Y(1994)Pharmacotherapy of delusional depression: experience with combinations of anti-depressants with the neuroleptics zotepine and haloperidol Neuropsychobiology 29 189-60

[4] Harada T(1995)Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use Pharmacopsychiatry 28 56-59

[5] Otsuki S(1990)The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment Eur J Pharmacol 186 49-73

[6] Wolfersdorf M(1996)Risperidone compared with new and reference antipsychotic drugs: Psychopharmacology (Berl) 124 57-8

[7] König F(1996) and Psychopharmacol Bull 32 123-6

[8] Straub R(1996) receptor binding Eur Neuropsychopharmacol 6 105-12

[9] Wolfersdorf M(1990)Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile Clin Neuropharmacol 13 500-54

[10] Barg T(1982)Comparison of the pharmacological profiles of zotepine and norzotepine [abstract] Jpn J Pharmacol 32 405-4